IMMUNOSCORE® For Patients Diagnosed With Localized Colon Cancer

Why Immunoscore®?

The seriousness of cancer, and particularly the colon cancer, is essentially gauged according to the extent the tumor (T) has spread within the affected organ, and whether it has spread to the lymph nodes (N) or to a different part of the body with metastases (M). This «TNM» classification distinguishes 5 different cancer stages (0 to IV) associated with different risk of recurrence following surgery (prognosis) and thus guides the choice of treatment.

However, this approach fails to account for the important role of the immune system.

The immune response can now be accurately measured in clinical practice with Immunoscore® to improve the estimation of risk of relapse.

What will your Immunoscore® results show?

Your Immunoscore® indicates the ability of your own body to fight cancer.

  • If your Immunoscore® is high, it means that you have a low risk of relapse.
  • Conversely, a low Immunoscore® is associated to a higher risk of relapse.

Download general presentation of Immunoscore® (EU version)


Your oncologist will use your Immunoscore® result in combination with other parameters to assess your risk of relapse and decide with you the most optimal treatment.

Discover how Immunoscore® is predicting the risk of relapse in localized colon cancer in a short video

Meet Jérôme Galon presenting Immunoscore®, a clearer cancer test

When and how to perform Immunoscore®?

After your surgery, a tissue sample from your tumor is preserved for further testing.

When your doctor orders Immunoscore® Colon, the hospital will send a portion of this sample to a HalioDx laboratory to perform the test.

You do NOT need to go through any additional procedure to get an Immunoscore® test.


Immunoscore® results are reported to your doctor within 10 working days of receipt of the specimen, giving a score - low, intermediate or high - which is your own Immunoscore®.

Talking to your oncologist about Immunoscore®

Each patient has their own level of risk, but how do you know what your risk is?

You’ve been diagnosed with colon cancer, it is critical that you get as much information as possible about your disease and discuss all your treatment options with your physician.

For localized (stage II and III) colon cancer patients, this discussion should include Immunoscore® as a new parameter to assess how your immune system fights the tumor and help to choose the appropriate treatment for your cancer.


For additional help in understanding colon cancer and your treatment options visit: or

or download ESMO/ACF Patient Guide for colorectal cancer: Colorectal-Cancer

For more information,contact your oncologist.


The information provided in this document is intended for patients who have been diagnosed with colon cancer. This document is not meant to provide medical advice.

The patient should discuss all treatment options with his or her physician.

Your contact:


Oncologists and patients are invited to contact HalioDx which markets and distributes Immunoscore® assay in your country.

Luminy Biotech Entreprises
163 Avenue de Luminy
13288 Marseille Cedex 9

Phone: +33 (0) 4 91 29 30 90

 contact customer service by mail

Contact us


By subscribing to our newsletter, you accept to receive information on our news and events by email. You can unsubscribe any time by clicking on the unsubscribe link at the bottom of our newsletters, or by sending us an unsubscribe request at privacy(at)haliodx(dot)com.

Fields marked with an asterisk (*) are required!

The information about you collected through this form is used by HalioDx to handle your request. Fields with an asterisk are mandatory. Otherwise, your request for information cannot be processed.
Your data will be processed by HalioDx authorized services, and might be transmitted to external service providers processing your data on behalf of HalioDx. For more information on protection mechanisms implemented, please contact the data Protection Officer: privacy(at)haliodx(dot)com.

As HalioDx contacts, your personal data are stored in our database system as long as your subscription to the newsletter or email services is active. Any recipient may request at any time to be removed from our contact database by writing an email to privacy(at)haliodx(dot)com with “I wish to be removed from your contact Database” in your subject line and we will comply with that request.